Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders

MONTREAL, April 15, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today anno